These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 20571484

  • 21. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
    Zaitone SA, El-Wakeil AF, Abou-El-Ela SH.
    Behav Pharmacol; 2012 Aug; 23(4):417-25. PubMed ID: 22750843
    [Abstract] [Full Text] [Related]

  • 22. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE, Gonzalez-Lira V, Horrillo I, Herrera-Marschitz M, Callado LF, Meana JJ.
    Eur J Pharmacol; 2013 Jun 05; 709(1-3):13-9. PubMed ID: 23562616
    [Abstract] [Full Text] [Related]

  • 23. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH, Selley DE, Lichtman AH, Sim-Selley LJ.
    Neuropsychopharmacology; 2010 Jul 05; 35(8):1775-87. PubMed ID: 20357755
    [Abstract] [Full Text] [Related]

  • 24. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V.
    Int Rev Neurobiol; 2009 Jul 05; 85():57-72. PubMed ID: 19607961
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
    Braida D, Capurro V, Zani A, Rubino T, Viganò D, Parolaro D, Sala M.
    Br J Pharmacol; 2009 Jul 05; 157(5):844-53. PubMed ID: 19422370
    [Abstract] [Full Text] [Related]

  • 27. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.
    Ferrés-Coy A, Santana N, Castañé A, Cortés R, Carmona MC, Toth M, Montefeltro A, Artigas F, Bortolozzi A.
    Psychopharmacology (Berl); 2013 Jan 05; 225(1):61-74. PubMed ID: 22820867
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA, Wise LE, Niyuhire F, Cravatt BF, Lichtman AH.
    Neuropsychopharmacology; 2007 May 05; 32(5):1032-41. PubMed ID: 17047668
    [Abstract] [Full Text] [Related]

  • 29. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.
    Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D.
    Proc Natl Acad Sci U S A; 2005 Dec 20; 102(51):18620-5. PubMed ID: 16352709
    [Abstract] [Full Text] [Related]

  • 30. Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task.
    Wise LE, Harloe JP, Lichtman AH.
    Neurobiol Learn Mem; 2009 Nov 20; 92(4):597-601. PubMed ID: 19524055
    [Abstract] [Full Text] [Related]

  • 31. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.
    Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH.
    Pharmacol Biochem Behav; 2011 Oct 20; 99(4):718-25. PubMed ID: 21740924
    [Abstract] [Full Text] [Related]

  • 32. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
    John CS, Currie PJ.
    Behav Brain Res; 2012 Aug 01; 233(2):382-8. PubMed ID: 22633963
    [Abstract] [Full Text] [Related]

  • 33. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F.
    Psychopharmacology (Berl); 2007 Apr 01; 191(3):745-58. PubMed ID: 17265076
    [Abstract] [Full Text] [Related]

  • 34. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH, Mendez-David I, Defaix C, Guiard BP, Tritschler L, David DJ, Gardier AM.
    Neuropharmacology; 2017 Jan 01; 112(Pt A):198-209. PubMed ID: 27211253
    [Abstract] [Full Text] [Related]

  • 35. Lack of CB1 receptor activity impairs serotonergic negative feedback.
    Aso E, Renoir T, Mengod G, Ledent C, Hamon M, Maldonado R, Lanfumey L, Valverde O.
    J Neurochem; 2009 May 01; 109(3):935-44. PubMed ID: 19302195
    [Abstract] [Full Text] [Related]

  • 36. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
    Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB.
    Neuropsychopharmacology; 2009 Jul 01; 34(8):1958-67. PubMed ID: 19322172
    [Abstract] [Full Text] [Related]

  • 37. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
    Schlosburg JE, Carlson BL, Ramesh D, Abdullah RA, Long JZ, Cravatt BF, Lichtman AH.
    AAPS J; 2009 Jun 01; 11(2):342-52. PubMed ID: 19430909
    [Abstract] [Full Text] [Related]

  • 38. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F, Lénárt N, Csibrány B, Sántha M, Molnár M, Tuka B, Samavati R, Klivényi P, Vécsei L, Marton A, Vizler C, Nagy GM, Borsodi A, Benyhe S, Páldy E.
    Neuropharmacology; 2015 Feb 01; 89():298-307. PubMed ID: 25446673
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.
    Anesth Analg; 2019 Aug 01; 129(2):587-597. PubMed ID: 29863609
    [Abstract] [Full Text] [Related]

  • 40. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO, Kuteeva E, Hökfelt T, Kehr J.
    CNS Drugs; 2006 Aug 01; 20(8):633-54. PubMed ID: 16863269
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.